Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -3.76 |
peg ratio | 0.04 |
price to book ratio | 30.44 |
price to sales ratio | 15.11 |
enterprise value multiple | -0.53 |
price fair value | 30.44 |
profitability ratios | |
---|---|
gross profit margin | 56.91% |
operating profit margin | -2975.47% |
pretax profit margin | -2936.5% |
net profit margin | -2936.5% |
return on assets | -170.65% |
return on equity | -303.2% |
return on capital employed | -431.7% |
liquidity ratio | |
---|---|
current ratio | 0.97 |
quick ratio | 0.91 |
cash ratio | 0.77 |
efficiency ratio | |
---|---|
days of inventory outstanding | 580.52 |
operating cycle | 725.02 |
days of payables outstanding | 2,200.90 |
cash conversion cycle | -1,475.87 |
receivables turnover | 2.53 |
payables turnover | 0.17 |
inventory turnover | 0.63 |
debt and solvency ratios | |
---|---|
debt ratio | 0.48 |
debt equity ratio | 2.28 |
long term debt to capitalization | 0.24 |
total debt to capitalization | 0.70 |
interest coverage | -32.91 |
cash flow to debt ratio | -2.96 |
cash flow ratios | |
---|---|
free cash flow per share | -1.47 |
cash per share | 0.44 |
operating cash flow per share | -1.35 |
free cash flow operating cash flow ratio | 1.09 |
cash flow coverage ratios | -2.96 |
short term coverage ratios | -4.44 |
capital expenditure coverage ratio | -11.55 |
Frequently Asked Questions
Mainz Biomed B.V. (MYNZ) published its most recent earnings results on 09-04-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Mainz Biomed B.V. (NASDAQ:MYNZ)'s trailing twelve months ROE is -303.2%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Mainz Biomed B.V. (MYNZ) currently has a ROA of -170.65%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
MYNZ reported a profit margin of -2936.5% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.97 in the most recent quarter. The quick ratio stood at 0.91, with a Debt/Eq ratio of 2.28.